Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 9711-9720 of 12000

Page
per page
  1. BMY 14802 hydrochloride
    B5112 BMY 14802 hydrochloride
    Summary: Sigma receptor antagonist
      <9.62 mg/mL
  2. DNQX disodium salt
    B5288 DNQX disodium salt
    Summary: Selective non-NMDA receptor antagonist
      <31.4 mg/mL
  3. Boc-L-Homoserine
    BA9302 Boc-L-Homoserine
    Summary: A serine derivative.
  4. Imidazole ketone erastin
    C8432 Imidazole ketone erastin
    Summary: A potent, metabolically stable systemic xc- inhibitor and iron apoptosis inducer
      ≥48.4 mg/mL
  5. CCT020312
    BA3586 CCT020312
    Summary: CCT020312 is a selective activator.
  6. Mertansine
    BA2321 Mertansine
    Summary: Mertansine (DM1) is an inhibitor and an antibody-conjugatable medetomidine alkaloid used to overcome the systemic toxicity associated with medetomidine and to enhance tumor-specific delivery.
      ≥26.65 mg/mL
  7. P 22077
    A8198 P 22077
    Summary: USP7/(DUB)USP47 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥14.6 mg/mL
  8. Aclacinomycin A
    A2601 Aclacinomycin A
    Target: Topoisomerases
    Summary: Topoisomerase I and II inhibitor
      Soluble in DMSO
  9. BMS-708163 (Avagacestat)
    A4022 BMS-708163 (Avagacestat)
    Summary: γ-secretase inhibitor
      insoluble in H2O; ≥177.6 mg/mL
  10. Rocilinostat (ACY-1215)
    A4083 Rocilinostat (ACY-1215)
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Selective HDAC6 inhibitor
      ≥21.675 mg/mL

Items 9711-9720 of 12000

Page
per page